AACE Media Center

The American Association of Clinical Endocrinologists (AACE) represents practicing clinicians and health care professionals who are experts in the treatment and management of endocrine and metabolic disorders. AACE welcomes the opportunity to provide disease state expertise and information via interviews with AACE member volunteers.

For media inquiries and/or interview requests, please contact:   [email protected]

Press Releases

When Salt IS Good for You: The Thyroid Health Connection

In recent years, medical journals and consumer publications alike have been hashing out the controversy about salt consumption and its effects on an array of medical conditions, primarily high blood pressure and heart disease, but also osteoporosis, kidney stones and kidney disease, and obesity.

Obesity Declared a Disease. So, What Happens Next?

In 2011, the American Association of Clinical Endocrinologists (AACE) Board of Directors declared obesity a disease state. And in 2013, the American Medical Association (AMA) agreed, approving an AACE-sponsored resolution on the floor of its House of Delegates. While many understood this to be a pivotal moment in the battle to curtail and reduce historic obesity rates, the question then heard most often was, “What happens next?”

New Diagnosis and Treatment of Obesity as Chronic Disease: American Association of Clinical Endocrinologists, American College of Endocrinology Publish Overarching Framework

The position statement is the outgrowth of AACE/ACE’s March 2014 AACE/ACE Consensus Conference on Obesity: Building an Evidence Base for Comprehensive Action, which convened in Washington, D.C. to identify the myriad of issues surrounding the obesity epidemic and generate a meaningful, medically actionable and economically viable model for diagnosis and treatment of obesity as a disease state.

AACE Announces Appearances by Actress Katee Sackhoff to Promote Thyroid Disease Awareness

A thyroid cancer survivor who was diagnosed and treated for the condition at age 27, Sackhoff will be joining nationally recognized thyroid expert and AACE member Dr. Jeffrey Garber for television appearances to advance knowledge about thyroid disease.

American Association of Clinical Endocrinologists Plans to Attack Epidemic of Obesity With Benchmark Gathering of Worldwide Experts

The AACE/ACE Consensus Conference on Obesity: Building an Evidence Base for Comprehensive Action will convene March 23-24, 2014 in Washington, D.C.  This conference is uniquely structured to consider research, information and opinions from all major stakeholders involved in the obesity arena. 

American Association of Clinical Endocrinologists Launches Endocrine-Focused Market Research Capability

ENDO360 meets the need of organizations that wish to conduct studies solely on endocrine- related diseases including thyroid, diabetes, osteoporosis, hormone deficiencies, obesity and more.

The American Association of Clinical Endocrinologists (AACE) and 42 National Medical Associations Urge Congress To Pass Key Legislation To Improve Diabetes Patient Care Before Adjournment

The National Diabetes Clinical Care Commission Act (H.R. 1074/S. 539) calls for the creation of a public/private commission of diabetes stakeholders whose purpose is to ensure the coordination of diabetes care activities that are currently managed by three dozen federal departments and agencies and to recommend new approaches to improve diabetes care.

American Association of Clinical Endocrinologists, American College of Endocrinology Announce Publication of First Disease State Commentary, Special Thyroid Section

The commentary, entitled “Molecular Diagnostic Testing of Thyroid Nodules with Indeterminate Cytopathology,” examines two so-called “molecular marker” tests utilized as an adjunct to fine-needle aspiration (FNA) biopsies in assessing the malignancy risk of thyroid nodules that have been classified as “indeterminate” via FNA, with the goal of providing physicians with a practical assessment of the tests’ value as a diagnostic tool.

Major Medical Association Announces Gathering of Key Diabetes Stakeholders to Tackle Challenges of Safety, Accuracy of Life-Saving Diabetes Patient Tools

The blood glucose monitoring initiative will be uniquely structured to gather input from all major stakeholders involved in the diabetes arena and will examine critical factors such as regulatory challenges, post-FDA-approval monitoring of safety and accuracy of glucose strips, glucose sensors and devices, patient access and economic/reimbursement issues.